Search
Search Results
##search.searchResults.foundPlural##
-
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4290PDF: 866HTML: 1297Table1: 164 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3659PDF: 1408HTML: 456Figures . Eliassian: 201 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1262PDF: 869Suppl. Files: 428HTML: 215 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1369PDF: 1004HTML: 205 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
897PDF: 1179HTML: 88 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1225PDF: 587HTML: 3051 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4185PDF: 1332HTML: 2022 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3985PDF: 1519HTML: 818 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1662PDF: 594HTML: 1497Figure 1: MRI demonstrating Aspergillus synovitis: 166Figure 2:MRI demonstrating Aspergillus synovitis: 163 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1860PDF: 703HTML: 677 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2709PDF: 929HTML: 3100flowcytometric result of peripheral blood sample: 155 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1810PDF: 869HTML: 1738Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 142 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1164PDF: 447HTML: 129 -
Pseudo-differentiation syndrome
1277PDF: 631HTML: 10828Figure 1: peripheral blood showing myeloblasts with auer rods: 105Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 93Figure 3: CXR showing pulmonary infiltartes with consolidation: 115Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 92Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 108 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1315PDF: 1267HTML: 78 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1128PDF: 682Html: 78 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2015PDF: 961HTML: 4046Cover Letter: 204Figure 1: 201Figure 2: 210Table 1: 186 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2352HTML: 251PDF: 817 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4645PDF: 1737HTML: 2094 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2314PDF: 958HTML: 1627Fig 1: 165Tab I: 190Cover Letter: 180 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
662PDF: 783PDF Supp. Files: 68HTML: 170 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1476PDF: 559HTML: 169 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3458PDF: 1441HTML: 4276CoverLetter: 167Figure1: 175 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3421PDF: 2325HTML: 1407 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
970PDF: 962HTML: 87 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
898PDF: 485HTML: 169







